Literature DB >> 17276019

Structure-based mutation analysis shows the importance of LRP5 beta-propeller 1 in modulating Dkk1-mediated inhibition of Wnt signaling.

Bheem M Bhat1, Kristina M Allen, Wei Liu, James Graham, Art Morales, Anthony Anisowicz, Ho-Sun Lam, Catherine McCauley, Valerie Coleburn, Michael Cain, Eric Fortier, Ramesh A Bhat, Frederick J Bex, Paul J Yaworsky.   

Abstract

A single point mutation (G to T) in the low-density lipoprotein receptor related protein 5 (LRP5) gene results in a glycine to valine amino acid change (G171V) and is responsible for an autosomal dominant high bone mass trait (HBM) in two independent kindreds. LRP5 acts as a co-receptor to Wnts with Frizzled family members and transduces Wnt-canonical signals which can be antagonized by LRP5 ligand, Dickkopf 1 (Dkk1). In the presence of Wnt1, LRP5 or the HBM variant (LRP5-G171V) induces beta-catenin nuclear translocation and activates T cell factor (TCF)-luciferase reporter activity. HBM variant suppresses Dkk1 function and this results in reduced inhibition of TCF activity as compared to that with LRP5. Structural analysis of LRP5 revealed that the HBM mutation lies in the 4th blade of the first beta-propeller domain. To elucidate the functional significance and consequence of the LRP5-G171V mutation in vitro, we took a structure-based approach to design 15 specific LRP5 point mutations. These included (a) substitutions at the G171 in blade 4, (b) mutations in blades 2-6 of beta-propeller 1, and (c) mutations in beta-propellers 2, 3 and 4. Here we show that substitutions of glycine at 171 to K, F, I and Q also resulted in HBM-like activity in the presence of Wnt1 and Dkk1. This indicates the importance of the G171 site rather than the effect of specific amino acid modification to LRP5 receptor function. Interestingly, G171 equivalent residue mutations in other blades of beta-propeller 1 (A65V, S127V, L200V, A214V and M282V) resulted in LRP5-G171V-like block of Dkk1 function. However G171V type mutations in other beta-propellers of LRP5 did not result in resistance to Dkk1 function. These results indicate the importance of LRP5 beta-propeller 1 for Dkk1 function and Wnt signaling. These data and additional comparative structural analysis of the LRP5 family member LDLR suggest a potential functional role of the first beta-propeller domain through intramolecular interaction with other domains of LRP5 wherein Dkk1 can bind. Such studies may also lead to a better understanding of the mechanisms underlying the reduced function of Dkk1-like inhibitory ligands of LRP5 with HBM-like mutations and its relationship to increased bone density phenotypes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17276019     DOI: 10.1016/j.gene.2006.12.014

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  20 in total

1.  Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5.

Authors:  C A Simpson; D Foer; G S Lee; J Bihuniak; B Sun; R Sullivan; J Belsky; K L Insogna
Journal:  Osteoporos Int       Date:  2014-06-14       Impact factor: 4.507

2.  Mechanotransduction in bone tissue: The A214V and G171V mutations in Lrp5 enhance load-induced osteogenesis in a surface-selective manner.

Authors:  Paul J Niziolek; Matthew L Warman; Alexander G Robling
Journal:  Bone       Date:  2012-06-28       Impact factor: 4.398

Review 3.  MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosis.

Authors:  Ernesto Canalis
Journal:  Eur J Endocrinol       Date:  2017-11-07       Impact factor: 6.664

4.  The first propeller domain of LRP6 regulates sensitivity to DKK1.

Authors:  Minke E Binnerts; Nenad Tomasevic; Jessica M Bright; John Leung; Victoria E Ahn; Kyung-Ah Kim; Xiaoming Zhan; Shouchun Liu; Shirlee Yonkovich; Jason Williams; Mei Zhou; Delphine Gros; Melissa Dixon; Wouter Korver; William I Weis; Arie Abo
Journal:  Mol Biol Cell       Date:  2009-05-28       Impact factor: 4.138

Review 5.  Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches.

Authors:  Ernesto Canalis
Journal:  Nat Rev Endocrinol       Date:  2013-08-13       Impact factor: 43.330

6.  The structural basis of DKK-mediated inhibition of Wnt/LRP signaling.

Authors:  Ju Bao; Jie J Zheng; Dianqing Wu
Journal:  Sci Signal       Date:  2012-05-15       Impact factor: 8.192

Review 7.  Genetics of osteoporosis: accelerating pace in gene identification and validation.

Authors:  Wen-Feng Li; Shu-Xun Hou; Bin Yu; Meng-Meng Li; Claude Férec; Jian-Min Chen
Journal:  Hum Genet       Date:  2009-12-12       Impact factor: 4.132

8.  Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism.

Authors:  Kyung Shin Kang; Jung Min Hong; Daniel J Horan; Kyung-Eun Lim; Whitney A Bullock; Angela Bruzzaniti; Steven Hann; Matthew L Warman; Alexander G Robling
Journal:  Bone       Date:  2018-10-25       Impact factor: 4.398

9.  High Bone Mass-Causing Mutant LRP5 Receptors Are Resistant to Endogenous Inhibitors In Vivo.

Authors:  Paul J Niziolek; Bryan T MacDonald; Rajendra Kedlaya; Minjie Zhang; Teresita Bellido; Xi He; Matthew L Warman; Alexander G Robling
Journal:  J Bone Miner Res       Date:  2015-10       Impact factor: 6.741

10.  Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo.

Authors:  Hong Y Choi; Marco Dieckmann; Joachim Herz; Andreas Niemeier
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.